NCT07138898 Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty Status NOT_YET_RECRUITING Phase PHASE2
NCT05960578 Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05669833 Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients Status RECRUITING Phase PHASE3
NCT05242484 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05242471 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05164198 REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST) Status UNKNOWN Phase PHASE4
NCT05071664 A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT04610476 Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis Status UNKNOWN Phase PHASE3
NCT04200833 Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis Failing Adalimumab Status COMPLETED Phase N/A
NCT04188249 Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis Status UNKNOWN Phase N/A
NCT04108468 GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA Status COMPLETED Phase PHASE3
NCT03945903 Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young Adults Status NO_LONGER_AVAILABLE Phase N/A
NCT03733925 A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis Status COMPLETED Phase PHASE4
NCT03632759 Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D Status COMPLETED Phase EARLY_PHASE1
NCT03596645 A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03414502 Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response Status RECRUITING Phase PHASE3